VC-backed arGEN-X raises €40m in IPO
Dutch VC-backed biotech arGEN-X has raised €40m from its IPO of new shares, giving it a market cap of €131.7m.
More on Benelux
European sponsors sidestep panic, concede gloom over bank woes
Fallout from Credit Suisse collapse adds to slew of macroeconomic challenges for PE dealmaking and fundraising
Deals face further financing uncertainty after Credit Suisse rescue
Delayed return of stabilized M&A conditions expected, advisors say; mid-cap transactions stand to fare best
Lenders sway fate of auctions in volatile LBO market
Vendors increasingly sounding out lenders before bidders to navigate uncertain M&A landscape
Keyhaven eyes Q4 2023 fund launch amidst lower mid-market GP-leds boom
Secondaries firm looks ahead to fourth fund; sweet spot of EUR 50m-100m for deals but can go up to EUR 500m
Latest News
GP Profile: BGF to deploy GBP 500m-plus per year for minority growth deals with entrepreneurs
UK and Ireland-based growth investor remains committed to filling a market gap for founders who want flexibility and control
European sponsors sidestep panic, concede gloom over bank woes
Fallout from Credit Suisse collapse adds to slew of macroeconomic challenges for PE dealmaking and fundraising
Inflexion sells The Goat Agency to trade, nets 80% IRR
GP sells minority stake in UK-based social media marketing agency after two year investment period
Synova kicks off new fund deployment with Learnlight acquisition
Investment in Spanish edtech platform is the first from GBP 875m vehicle raised in three months last year